Glenview State Bank Trust Department’s Biogen BIIB Stock Holding History

Glenview State Bank Trust Department’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-723	Closed	-$255K	–	102
2018 Q3	$255K	Sell	723 -30	-4%	-$10.3K	0.11%	87
2018 Q2	$219K	Buy	+753	New	+$212K	0.1%	91
2015 Q3	–	Sell	-575	Closed	-$232K	–	86
2015 Q2	$232K	Buy	+575	New	+$231K	0.14%	82

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview State Bank Trust Department's BIIB Position: Q4 2018 in Review

Glenview State Bank Trust Department sold out of Biogen (BIIB) in Q4 2018, closing a stake of 723 shares — an estimated $255K sold.

Glenview State Bank Trust Department first reported a position in BIIB in Q2 2015 and held it in 3 quarters. The position peaked at $255K in Q3 2018. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Glenview State Bank Trust Department reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Glenview State Bank Trust Department sold 723 Biogen shares in Q4 2018, an estimated $255K.
Glenview State Bank Trust Department first reported a position in Biogen in Q2 2015 and held it in 3 quarters.
Glenview State Bank Trust Department's Biogen position peaked at $255K in Q3 2018.
1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Glenview State Bank Trust Department's 13F filing for Q4 2018, filed 30 Jan 2019.